Viewing Study NCT01214733


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-04-09 @ 11:39 AM
Study NCT ID: NCT01214733
Status: COMPLETED
Last Update Posted: 2015-12-02
First Post: 2010-10-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module